Dow Up 0.15% Nasdaq Up 0.21%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
5.91 0.03(0.51%) Sep 17, 4:00PM EDT
Prev Close:5.88
Open:5.88
Bid:5.77 x 100
Ask:5.98 x 900
1y Target Est:8.72
Beta:1.51
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.85 - 5.98
52wk Range:2.15 - 21.55
Volume:4,671,871
Avg Vol (3m):7,270,110
Market Cap:1.11B
P/E (ttm):N/A
EPS (ttm):-1.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIAUp 0.51%1.11B
NVS229.81B
PFE192.45B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.15
Quarterly EPS Est (Sep-14) :-0.30
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback